Vivorté, Inc., a vertically-integrated, specialty orthopedic biomaterials company, announced the commercial availability of a complete line of bone grafting product solutions.
Citing BioMedGPS SmartTRAK, Vivorté, Inc. wrote "According to BioMedGPS, the current market for bone graft substitute products exceeds $1.7B annually in the United States alone." Read the Release: "Vivorté announces the commercial availability of FORTERA and REGENTO bone grafting solutions for orthopedic surgery"
Topics: Orthopedics
Founder, President and Chief Executive Officer Founder, former President & CEO, Medtech Insight, 25+ years' experience in the Medical Device industry in Sales, Marketing, Business Development, Consulting with major manufacturers (J&J, Pfizer, US Surgical), start-up companies and business intelligence providers (Medical Data International, Windhover Information)
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.
